NLCP.OQXNewlake Capital Partners, INC

8-K: NewLake Capital Partners Reports Steady Q1 2025 Financial Results Amidst Industry Challenges

Sentiment:

Earnings Release

📋All filings for Newlake Capital Partners, INC
🔒Login to Follow

NewLake Capital Partners announces Q1 2025 financial results, highlighting consistent revenue and rent collections despite a challenging industry landscape.

Summary

  • NewLake Capital Partners reported its financial results for the first quarter ended March 31, 2025.
  • Revenue totaled $13.2 million, a 4.8% increase year-over-year.
  • Net income attributable to common stockholders was $6.3 million.
  • Funds From Operations (FFO) totaled $10.3 million.
  • Adjusted Funds From Operations (AFFO) totaled $10.7 million.
  • The company declared a first quarter dividend of $0.43 per common share, equivalent to an annualized dividend of $1.72 per common share.
  • Approximately 98% of contractual rent was collected during the quarter.
  • Cash and cash equivalents as of March 31, 2025, were $19.9 million, with $11.7 million committed to fund future improvements.
  • Total liquidity was $102.3 million, including availability under the revolving credit facility.
  • Gross real estate assets totaled $431.7 million.
  • The debt to total gross assets ratio was 1.6%, with a debt service coverage ratio of approximately 113x.
  • There are no debt maturities until May 2027.
  • The company amended leases with Revolutionary Clinics and Calypso during the fourth quarter of 2023 due to operating challenges.
  • Revolutionary Clinics paid approximately 50% of its contractual rent from June 2024 through March 2025 and entered into receivership on December 13, 2024.
  • Calypso Enterprises paid all rent due for the three months ended March 31, 2025, after a financial restructuring.
  • As of March 31, 2025, the company had $7.6 million in borrowings under the Revolving Credit Facility and $82.4 million available to be drawn.
  • The facility bears interest at a fixed rate of 5.65% through May 5, 2025, and thereafter a variable rate.
  • The company has not issued any shares under the ATM Program as of March 31, 2025.

Sentiment

Score: 7

Explanation: The document presents a balanced view, highlighting both positive financial results and challenges faced by the company. While revenue increased and rent collections remained high, there were decreases in net income, FFO, and AFFO, along with tenant defaults. The management expresses confidence in the company's strategy and execution, but the risks associated with the cannabis industry and tenant performance are acknowledged.

Positives

  • Revenue increased by 4.8% year-over-year to $13.2 million.
  • The company maintained a high rent collection rate of 98%.
  • A dividend of $0.43 per common share was declared, representing a 4.9% increase compared to the previous year.
  • The company has significant liquidity with $102.3 million available.
  • The debt to total gross assets ratio is low at 1.6%.
  • There are no debt maturities until May 2027.
  • The company's investor presentation highlights that the dividend has grown 79% since the IPO.
  • The investor presentation highlights that the company is undervalued compared to REIT peers.

Negatives

  • Net income attributable to common stockholders decreased from $6.9 million to $6.3 million year-over-year.
  • FFO decreased by 2.6% year-over-year to $10.3 million.
  • AFFO decreased by 2.2% year-over-year to $10.7 million.
  • Two tenants defaulted on their lease agreements, impacting net income, FFO, and AFFO.
  • Revolutionary Clinics entered into receivership and paid only 50% of contractual rent from June 2024 through March 2025.

Risks

  • The cannabis industry faces a challenging landscape and a volatile macroeconomic environment.
  • Two tenants defaulted on their lease agreements, impacting financial performance.
  • Revolutionary Clinics entered into receivership, creating uncertainty about future rent payments.
  • The company's financial performance is subject to the operating challenges of its tenants.
  • The company's forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances.

Future Outlook

The company anticipates continued growth in the cannabis industry and believes its focus on limited-license jurisdictions and strong tenant relationships will drive future success. The company is focused on disciplined risk management and proactive portfolio construction.

Management Comments

  • Our first quarter financial results underscore the consistency and resilience of our portfolio, said Anthony Coniglio, NewLakes President and Chief Executive Officer.
  • Rent collections were in line with expectations, and we delivered an 84% AFFO payout ratio.
  • Im proud of how our team continues to execute in a challenging industry landscape and a volatile macroeconomic environment.
  • These consistent results reflect the benefits of the proactive steps weve taken in portfolio construction and disciplined risk management.

Industry Context

NewLake Capital Partners operates in the cannabis real estate sector, providing capital to state-licensed cannabis operators. The industry is experiencing growth due to increasing acceptance of cannabis nationally and state-level growth catalysts. The company's focus on limited-license jurisdictions and strong tenant relationships positions it for continued growth.

Comparison to Industry Standards

  • The investor presentation compares NewLake's dividend yield, price to book, debt to equity, and AFFO multiple to IIPR, non-cannabis REIT peers (NNN, PSTL, VICI, FCPT, NTST, EPRT), and cannabis mortgage REIT peers (REFI and AFCG).
  • NewLake's dividend yield is 11.9% as of May 6, 2025, compared to IIPR's 14.3% and an average of 5.4% for non-cannabis REIT peers.
  • NewLake's price to book is 0.7x as of May 6, 2025, compared to IIPR's 0.8x and an average of 1.5x for non-cannabis REIT peers.
  • NewLake's Q1 debt to equity is 1.9%, compared to IIPR's 15.5% and an average of 77.5% for non-cannabis REIT peers.
  • NewLake's AFFO multiple is 7.1x, compared to IIPR's 6.8x and an average of 13.6x for both non-cannabis REIT peers and cannabis mortgage REIT peers.

Stakeholder Impact

  • Shareholders will receive a dividend of $0.43 per common share.
  • Employees will continue to execute the company's strategy in a challenging industry landscape.
  • Tenants will be supported through proactive portfolio management and strategic divestiture of underutilized assets.
  • The company's financial performance will impact its ability to provide capital to state-licensed cannabis operators.

Next Steps

  • Management will host a conference call and webcast on May 8, 2025, to discuss the quarterly financial results.
  • The company will continue to monitor the performance of its tenants and manage its portfolio proactively.
  • The company will continue to evaluate investment opportunities in the cannabis real estate sector.

Key Dates

DateDescription
October 31, 2019Acquisition date of Acreage Massachusetts Sterling cultivation property.
October 31, 2019Acquisition date of Acreage Pennsylvania Sinking Springs cultivation property.
December 23, 2019Acquisition date of The Cannabist Company Illinois Chicago dispensary property.
December 23, 2019Acquisition date of The Cannabist Company Massachusetts Greenfield dispensary property.
December 23, 2019Acquisition date of The Cannabist Company California San Diego dispensary property.
December 23, 2019Acquisition date of The Cannabist Company Illinois Aurora cultivation property.
December 31, 2019Acquisition date of Cresco Labs Illinois Lincoln cultivation property.
January 31, 2020Acquisition date of Curaleaf Illinois Chicago dispensary property.
January 31, 2020Acquisition date of Curaleaf North Dakota Minot dispensary property.
January 31, 2020Acquisition date of Curaleaf Pennsylvania King of Prussia dispensary property.
January 31, 2020Acquisition date of Curaleaf Illinois Litchfield dispensary property.
January 31, 2020Acquisition date of Curaleaf Illinois Mokena dispensary property.
January 31, 2020Acquisition date of Curaleaf Illinois Morris dispensary property.
January 31, 2020Acquisition date of CODES Arkansas Little Rock dispensary property.
February 28, 2020Acquisition date of Curaleaf Connecticut Groton dispensary property.
February 28, 2020Acquisition date of Curaleaf Ohio Newark dispensary property.
February 28, 2020Acquisition date of Curaleaf Pennsylvania Morton dispensary property.
February 28, 2020Acquisition date of PharmaCann Pennsylvania Shamokin dispensary property.
February 28, 2020Acquisition date of PharmaCann Massachusetts Shrewsbury dispensary property.
March 30, 2021Acquisition date of Mint Arizona Phoenix cultivation property.
August 31, 2021Acquisition date of Curaleaf Florida Mt. Dora cultivation property.
November 1, 2021Acquisition date of Calypso Pennsylvania Erie cultivation property.
December 20, 2021Acquisition date of CODES Missouri Chaffee cultivation property.
April 1, 2022Acquisition date of C3 Industries Missouri O'Fallon cultivation property.
June 30, 2022Acquisition date of Ayr Wellness Pennsylvania Pottsville cultivation property.
June 30, 2022Acquisition date of Ayr Wellness Nevada Sparks cultivation property.
November 4, 2022Acquisition date of PharmaCann Ohio Wapakoneta dispensary property.
May 8, 2024Acquisition date of C3 Industries Connecticut East Hartford cultivation property.
June 2024Revolutionary Clinics began paying approximately 50% of its contractual rent.
February 19, 2025Acquisition date of Cresco Labs Ohio Proctorville dispensary property.
March 4, 2025The company's Board of Directors declared a first quarter 2025 cash dividend of $0.43 per share.
March 31, 2025End of the first quarter for which financial results are reported.
April 15, 2025Dividend was paid to stockholders of record at the close of business on March 31, 2025.
May 5, 2025Fixed interest rate of 5.65% on the Revolving Credit Facility ends.
May 7, 2025Date of the 8-K filing and press release announcing Q1 2025 financial results.
May 8, 2025Conference call and webcast to discuss quarterly financial results.
May 8, 2025Date of the investor presentation.
May 22, 2025Dial-in replay of the conference call will be available until this date.
May 2027No debt maturity until this date.

Keywords

NewLake Capital Partners, cannabis, real estate, REIT, financial results, revenue, rent collection, FFO, AFFO, dividend, lease, tenants

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.